Ajanta-Pharma Stock/Share Prices, Buy and Sell Ajanta-Pharma BSE Stocks

Ajanta Pharma Ltd NSE / BSE
Pharmaceuticals, Large Cap

Invest

19 Nov 2018 | 11:00 AM

1,107.40

-12.25 (-1.09%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-12.92%

Return (1Y)

Underperformed S&P BSE Healthcare by 18.41%
More Volatile

2.22%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 1.1%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,592

898

News & Announcements

Board of Ajanta Pharma recommends interim dividend
17 days ago

Board of Ajanta Pharma recommends interim dividend

01 - Nov - 2018 12:00 AM | 17 days ago

Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 31 October 2018, inter alia, have recommended the interim dividend of Rs 9 per equity Share (i.e. 450%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
Ajanta Pharma consolidated net profit declines 4.93% in the September 2018 quarter
18 days ago

Ajanta Pharma consolidated net profit declines 4.93% in the September 2018 quarter

31 - Oct - 2018 12:00 AM | 18 days ago

Net profit of Ajanta Pharma declined 4.93% to Rs 125.39 crore in the quarter ended September 2018 as against Rs 131.89 crore during the previous quarter ended September 2017. Sales rose 0.69% to Rs 544.11 crore in the quarter ended September 2018 as against Rs 540.38 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 544.11 540.38 1
OPM % 30.55 34.00 -
PBDT 181.33 192.82 -6
PBT 163.84 178.27 -8
NP 125.39 131.89 -5
Powered by Capital Market - Live News
Ajanta Pharma standalone net profit declines 3.34% in the September 2018 quarter
18 days ago

Ajanta Pharma standalone net profit declines 3.34% in the September 2018 quarter

31 - Oct - 2018 12:00 AM | 18 days ago

Net profit of Ajanta Pharma declined 3.34% to Rs 104.10 crore in the quarter ended September 2018 as against Rs 107.70 crore during the previous quarter ended September 2017. Sales declined 0.82% to Rs 465.29 crore in the quarter ended September 2018 as against Rs 469.14 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 465.29 469.14 -1
OPM % 30.51 33.56 -
PBDT 158.84 165.32 -4
PBT 141.98 151.37 -6
NP 104.10 107.70 -3
Powered by Capital Market - Live News
Ajanta Pharma fixes record date for interim dividend
18 days ago

Ajanta Pharma fixes record date for interim dividend

31 - Oct - 2018 12:00 AM | 18 days ago

Ajanta Pharma has fixed 12 November 2018 as record date for interim dividend. The dividend will be paid on or after 15 November 2018.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Ajanta Pharma Ltd has increased by 3.85% since past 3 Months
FII shareholding in Ajanta Pharma Ltd has decreased by -10.44% since past 1 Year
MF shareholding in Ajanta Pharma Ltd has increased by 47.77% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	544.11	540.38	1
OPM %	30.55	34.00	-
PBDT	181.33	192.82	-6
PBT	163.84	178.27	-8
NP	125.39	131.89	-5

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	465.29	469.14	-1
OPM %	30.51	33.56	-
PBDT	158.84	165.32	-4
PBT	141.98	151.37	-6
NP	104.10	107.70	-3

General Notifications

My Notifications

Research Notifications

Ajanta Pharma Ltd NSE / BSE Pharmaceuticals, Large Cap

1,107.40 -12.25 (-1.09%)

News & Announcements

Price vs Volume

Stock Trivia

Ajanta Pharma Ltd NSE / BSE
Pharmaceuticals, Large Cap

1,107.40

-12.25 (-1.09%)